Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
636 ARTÍCULOS , VIENDO DEL 286 AL 300
Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease
Seyfried TN, Choi H, Chevalier A, Hogan D, Akgoc Z, Schneider JS.
ASN Neuro. 2018 Jan-Dec;10:1759091418781889. doi: 10.1177/1759091418781889.
Now is the Critical Time for Engineered Neuroplasticity
Moritz CT.
Neurotherapeutics. 2018 Jul;15(3):628-634. doi: 10.1007/s13311-018-0637-0.
MRI-based neuroimaging: atypical parkinsonisms and other movement disorders
Kassubek J.
Curr Opin Neurol. 2018 Aug;31(4):425-430. doi: 10.1097/WCO.0000000000000578.
Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T.
Neurodegener Dis Manag. 2018 Oct;8(5):349-360. doi: 10.2217/nmt-2018-0020. Epub 2018 Jul 5.
Comparison of computerized methods for rapid eye movement sleep without atonia detection
Cesari M, Christensen JAE, Kempfner L, Olesen AN, Mayer G, Kesper K, Oertel WH, Sixel-Döring F, Trenkwalder C, Sorensen HBD, Jennum P.
Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy133.
Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, Onuk K, Odin PLA.
Curr Med Res Opin. 2018 Dec;34(12):2063-2073. doi: 10.1080/03007995.2018.1502165. Epub 2018 Aug 20.
Regenerative Therapies for Parkinson's Disease: An Update
Stoker TB, Barker RA.
BioDrugs. 2018 Aug;32(4):357-366. doi: 10.1007/s40259-018-0294-1.
Ward KM, Citrome L.
Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19.
Pahwa R, Isaacson SH, Torres-Russotto D, Nahab FB, Lynch PM, Kotschet KE.
Expert Rev Neurother. 2018 Aug;18(8):669-680. doi: 10.1080/14737175.2018.1503948. Epub 2018 Jul 26.
Do Video House Calls With a Specialist Help Get Care to People With Parkinson's Disease?
Dorsey ER, Achey MA, Korn RE, Arky A, Beck CA, Biglan KM, Stevenson EA, Zhu W, Mammen JR, Elson MJ.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Aug.
Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Ferini-Strambi L, Carli G, Casoni F, Galbiati A.
Front Neurol. 2018 Jul 24;9:551. doi: 10.3389/fneur.2018.00551. eCollection 2018.
Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial
Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP.
Mov Disord. 2018 Aug;33(8):1306-1314. doi: 10.1002/mds.27390. Epub 2018 Aug 11.
What influences placebo and nocebo responses in Parkinson's disease?
Witek N, Stebbins GT, Goetz CG.
Mov Disord. 2018 Aug;33(8):1204-1212. doi: 10.1002/mds.27416. Epub 2018 Aug 22.
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features
Ray Chaudhuri K, Poewe W, Brooks D.
Mov Disord. 2018 Jul;33(6):909-919. doi: 10.1002/mds.27386.
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.
Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.